Oral misoprostol ( PGE1 ) vs vaginal dinoprostone ( PGE2 ) for labor induction: individual participant data meta‐analysis of randomized controlled trials
Ultrasound in Obstetrics & Gynecology · 2025
DOI: 10.1002/uog.70100 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2025. Verfasst von S Y Tan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia. Hauptthemen laut MEDLINE: Misoprostol, Labor, Induced, Dinoprostone, Oxytocics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Objective
To compare the effectiveness and safety of oral misoprostol vs vaginal dinoprostone for the induction of labor (IOL) using an individual participant data (IPD) meta‐analysis.
Methods
We used a Cochrane review and searched Ovid MEDLINE, Ovid Embase, Ovid Emcare, CINAHL Plus, Scopus and ClinicalTrials.gov to identify randomized controlled trials (RCTs) that compared oral misoprostol with vaginal dinoprostone for IOL in viable singleton pregnancies. We invited the authors of eligible trials to share their anonymized data. Primary outcomes were vaginal delivery, a composite measure of adverse maternal outcomes and a composite measure of adverse perinatal outcomes. IPD meta‐analysis was conducted using a two‐stage random‐effects model. An intention‐to‐treat approach was used for all analyses. Aggregate‐data meta‐analysis was undertaken with RCTs stratified by Trustworthiness in RAndomised Clinical Trials (TRACT) score.
Results
Of 18 eligible RCTs, eight provided IPD, of which five (1892 participants) met the TRACT criteria for trustworthiness. IPD meta‐analysis showed similar rates of vaginal delivery after IOL with oral misoprostol or vaginal dinoprostone (odds ratio (OR), 0.99 (95% CI, 0.80–1.22); I 2 = 0%). The rates of composite adverse perinatal outcome (adjusted odds ratio (aOR), 1.02 (95% CI, 0.61–1.72); I 2 = 0%) and composite adverse maternal outcome (aOR, 1.39 (95% CI, 0.72–2.69); I 2 = 0%) were also comparable between the groups. Of 10 RCTs that did not share IPD, seven met the TRACT criteria. Aggregate‐data meta‐analysis of the 12 RCTs (five with IPD and seven without IPD) meeting the trustworthiness criteria also showed comparable rates of vaginal delivery after oral misoprostol and after vaginal dinoprostone (OR, 1.08 (95% CI, 0.92–1.27)). In contrast, six studies not meeting the trustworthiness criteria (three with and three without IPD) reported a higher rate of vaginal delivery following oral misoprostol (OR, 1.34 (95% CI, 1.22–1.48)), resulting in an inflated overall estimate of the vaginal delivery rate after oral misoprostol based on all data (OR, 1.19 (95% CI, 1.05–1.36)).
Conclusion
IOL with oral misoprostol or vaginal dinoprostone results in comparable rates of vaginal delivery and composite perinatal and maternal adverse outcomes. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia.
- Department of Obstetrics and Gynaecology, Monash Health, Clayton, VIC, Australia.
- Department of Obstetrics and Gynaecology and Robinson Research Institute, University of Adelaide, Women's and Children's Hospital, North Adelaide, SA, Australia.
- Women's and Babies Division, Women's and Children's Hospital, North Adelaide, SA, Australia.
- Department of Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa.
- Department of Obstetrics and Gynaecology, Dalhousie University, IWK Health Centre, Halifax, NS, Canada.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Tan, S. Y., Au, N., Peel, M. D., Dodd, J. M., Deussen, A., Le Roux, P. A., Young, D. C., Tessier, F., Dallenbäch, P., Croll, D. M. R., Patabendige, M., Palmer, K., Li, W., & Mol, B. W. (2025). Oral misoprostol ( PGE1 ) vs vaginal dinoprostone ( PGE2 ) for labor induction: individual participant data meta‐analysis of randomized controlled trials. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.70100
Vancouver
Tan SY, Au N, Peel MD, Dodd JM, Deussen A, Le Roux PA, et al. Oral misoprostol ( PGE1 ) vs vaginal dinoprostone ( PGE2 ) for labor induction: individual participant data meta‐analysis of randomized controlled trials. Ultrasound in Obstetrics & Gynecology. 2025. doi:10.1002/uog.70100
BibTeX
@article{Tan2025,
author = {Tan, S Y and Au, N and Peel, M D and Dodd, J M and Deussen, A and Le Roux, P A and Young, D C and Tessier, F and Dallenbäch, P and Croll, D M R and Patabendige, M and Palmer, K and Li, W and Mol, B W},
title = {Oral misoprostol ( PGE1 ) vs vaginal dinoprostone ( PGE2 ) for labor induction: individual participant data meta‐analysis of randomized controlled trials},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2025},
doi = {10.1002/uog.70100}
}
EUVIMED